Company: SMNR
Filing Date: 2025-06-11
Form Type: S-4/A
Source: 0001193125-25-139124
Chunk: 303

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-06-11
Form: S-4/A
Chunk 303
---
 fixed the close of business on , 2025, as the Record Date for determining those Denali shareholders entitled to notice of and to vote at the Meeting. As of the close of business on , 2025, there were 2,616,239 Denali Ordinary Shares issued and outstanding and entitled to vote, of which 43,739 are public shares (which includes 14,622 shares underlying the Public Units), 2,062,500 are Denali Class B Ordinary Shares held by the Initial Shareholders and Scilex and 510,000 are Denali Class A Ordinary Shares underlying the Denali Private Placement Units held by the Sponsor. Each holder of Denali Ordinary Shares is entitled to one vote per share on each Proposal; provided that holders of Denali Class B Ordinary Shares will have ten votes per share solely with respect to the Domestication Proposal. If your shares are held in “street name,” you should contact your broker, bank or other nominee to ensure that shares held beneficially by you are voted in accordance with your instructions.

In connection with the IPO, we entered into certain letter agreements pursuant to which the Initial Shareholders agreed to vote any Denali Ordinary Shares owned by them in favor of our initial business combination. The Initial Shareholders also entered into a certain support agreement with Semnur, pursuant to which they agreed to, among other things, vote in favor of the Business Combination Proposal and the other proposals. As of the date of this proxy statement/prospectus, the Initial Shareholders hold approximately 59.7% of the outstanding Denali Ordinary Shares.

Quorum and Required Vote for Shareholder Proposals

A quorum of Denali’s shareholders is necessary to hold a valid meeting. The presence, in person or by proxy, of Denali’s shareholders representing a majority of the Denali Ordinary Shares as of the Record Date and entitled to vote at the Meeting will constitute a quorum for the Meeting. A quorum will be present at the Meeting if 1,407,169 Denali Ordinary Shares are present in person or represented by proxy.

Approval of the Business Combination Proposal, the Advisory Governance Proposal, the Director Election Proposal, the Nasdaq Proposal, the Option Exchange Proposal and the Adjournment Proposal will each require an ordinary resolution under Cayman Islands law, being the affirmative vote of the majority of the Denali Ordinary Shares present in person or represented by proxy and entitled to vote thereon and who vote at the Meeting or any adjournment or postponement thereof. In accordance with the